Vincerx Pharma (VINC) SEC Filings & 10K Form $0.03 +0.00 (+3.50%) As of 09/5/2025 03:53 PM Eastern Add Compare Share Share SEC Filings Stock AnalysisAnalyst ForecastsChartCompetitorsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Recent Vincerx Pharma SEC Filings All Filing Types 1 10 10-D 10-K 10-M 10-Q 11-K 12b-25 13F 13H 144 15 15F 17-H 18 18-K 19b-4(e) 19b-4 19b-7 1-A 1-E 1-K 1-N 1-SA 1-U 1-Z 20-F 24F-2 25 2-E 3 4 40-F 5 6-K 7-M 8-A 8-K 8-M 9-M ABS DD-15E ABS-15G ABS-EE ADV ADV-E ADV-H ADV-NR ADV-W ATS ATS-R BD BD-N BDW C CA-1 CB CFPORTAL D F-1 F-10 F-3 F-4 F-6 F-7 F-8 F-80 F-N F-X ID MA MA-I MA-NR MA-W MSD MSDW n/a N-14 N-17D-1 N-17f-1 N-17f-2 N-18f-1 N-1A N-2 N-23c-3 N-27D-1 N-3 N-4 N-5 N-54A N-54C N-6 N-6EI-1 N-6F N-8A N-8B-2 N-8B-4 N-8F N-CR N-CSR N-MFP N-PX N-Q NRSRO N-SAR PF PILOT R31 S-1 S-11 S-20 S-3 S-4 S-6 S-8 SBSE SBSE-A SBSE-BD SBSE-C SBSE-W SCI SD SDR SE SF-1 SF-3 SIP T-1 T-2 T-3 T-4 T-6 TA-1 TA-2 TA-W TCR TH WB-APP X-17A-19 X-17A-5 Part I X-17A-5 Part II X-17A-5 Part IIA X-17A-5 Part IIB X-17A-5 Part III X-17A-5 Schedule I X-17F-1A Filing Types Include Ownership Filings Exclude Ownership Filings Only Show Ownership FIlings Ownership Filings Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel DateFilerForm TypeView07/29/20254:55 PMSAGE RHINO CAPITAL LLC (Filed by)Vincerx Pharma (Subject)Form SCHEDULE 13G/A07/16/20253:14 PMVincerx Pharma (Filer)Form DEFA14A07/07/20253:23 PMVincerx Pharma (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 07/07/20253:27 PMVincerx Pharma (Filer)Form DEFA14A06/18/20253:18 PMVincerx Pharma (Filer)Form DEFA14A05/15/20252:13 PMARMISTICE CAPITAL, LLC (Filed by)Vincerx Pharma (Subject)Form SCHEDULE 13G/A05/12/20253:49 PMVincerx Pharma (Filer)Form DEF 14A05/04/202511:15 PMVincerx Pharma (Filer)Form EFFECT05/04/202511:15 PMVincerx Pharma (Filer)Form EFFECT05/04/202511:15 PMVincerx Pharma (Filer)Form EFFECT05/01/20254:06 PMVincerx Pharma (Filer)Form POS AM Get the Latest News and Ratings for VINC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Vincerx Pharma and its competitors with MarketBeat's FREE daily newsletter. 05/01/20254:07 PMVincerx Pharma (Filer)Form POS AM05/01/20254:08 PMVincerx Pharma (Filer)Form POS AM05/01/20254:10 PMVincerx Pharma (Filer)Form S-8 POS05/01/20254:11 PMVincerx Pharma (Filer)Form S-8 POS05/01/20254:11 PMVincerx Pharma (Filer)Form S-8 POS05/01/20254:12 PMVincerx Pharma (Filer)Form S-8 POS05/01/20254:13 PMVincerx Pharma (Filer)Form S-8 POS04/30/20253:41 PMVincerx Pharma (Filer)Form PRE 14A04/17/20253:52 PMVincerx Pharma (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 04/11/20253:03 PMVincerx Pharma (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 04/02/202511:15 PMVincerx Pharma (Filer)Form EFFECT03/31/20253:02 PMVincerx Pharma (Filer)Form S-3/A03/18/20258:02 AMVincerx Pharma (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 03/18/20258:05 AMVincerx Pharma (Subject)Form 42502/12/20257:30 AMProsight Management, LP (Filed by)Vincerx Pharma (Subject)Form SCHEDULE 13G/A02/11/20256:09 PMLong Focus Capital Management, LLC (Filed by)Vincerx Pharma (Subject)Form SCHEDULE 13G/A02/06/20253:05 PMVincerx Pharma (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 02/06/20253:06 PMVincerx Pharma (Filer)Form DEFA14A01/29/20253:05 PMVincerx Pharma (Filer)Form DEFA14A01/23/20253:10 PMVincerx Pharma (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 01/23/20253:13 PMVincerx Pharma (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 01/23/20253:15 PMVincerx Pharma (Filer)Form DEFA14A01/21/20253:31 PMVincerx Pharma (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 01/21/20253:29 PMVincerx Pharma (Filer)Form 424B501/16/20254:11 PMVincerx Pharma (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 12/27/20243:12 PMVincerx Pharma (Filer)Form 424B512/27/20243:13 PMVincerx Pharma (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 11/25/20244:05 PMVincerx Pharma (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 11/14/202410:57 AMBANK OF AMERICA CORP /DE/ (Filed by)Vincerx Pharma (Subject)Form SC 13G/A11/13/20247:32 AMProsight Management, LP (Filed by)Vincerx Pharma (Subject)Form SC 13G/A11/05/20248:15 AMVincerx Pharma (Filer)Form PRE 14A09/30/20245:57 AMVincerx Pharma (Subject)Form SC TO-I/A09/10/20243:02 PMVincerx Pharma (Subject)Form SC TO-I/A(Data available from 1/1/2016 forward) Related Companies and Tools Related Companies Bon Natural Life SEC Filings Trevena SEC Filings NuCana SEC Filings Smart for Life SEC Filings Syros Pharmaceuticals SEC Filings Navidea Biopharmaceuticals SEC Filings ObsEva SEC Filings Scopus BioPharma SEC Filings Virpax Pharmaceuticals SEC Filings Statera Biopharma SEC Filings SEC Filings Tools Latest SEC FilingsInsider Trading Activity This page (NASDAQ:VINC) was last updated on 9/7/2025 by MarketBeat.com Staff From Our PartnersYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | Sponsored2013 Bitcoin miner reveals his trading system (free)While everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vincerx Pharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vincerx Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
